{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Juvenile dermatomyositis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_chloroquine",
          "name": "Chloroquine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_d_penicillamine",
          "name": "D-penicillamine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_interferon_alpha",
          "name": "Interferon-alpha"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_nivolumab",
          "name": "Nivolumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.85,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.9,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Methotrexate 被广泛用于治疗自身免疫性疾病，并与 JDM 的路径逻辑相符"
          ],
          "indication_plausibility": [
            "已经确认其禁忌，包括与免疫抑制相关的潜在风险"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.82,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.65,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.85,
          "safety_risk": 0.05,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.08
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Azathioprine 对 JDM 的免疫抑制作用得到了较强的理论支持"
          ],
          "indication_plausibility": [
            "禁忌是基于免疫抑制相关风险"
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.79,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.8,
          "safety_risk": 0.15,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Cyclophosphamide 在某些情况下会加重 JDM 的症状"
          ],
          "safety_risk": [
            "存在对 JDM 的潜在加重风险，显示出区别点"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.8,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Chloroquine 需要谨慎使用，可能存在一些禁忌"
          ],
          "indication_plausibility": [
            "其疗效与安全性参数相对较高，但需针对个体评估"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.73,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.55,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.75,
          "safety_risk": 0.2,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "D-penicillamine 可能影响病情，需谨慎评估"
          ],
          "indication_plausibility": [
            "显示出与 JDM 相关的可能性"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.68,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.55,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Prednisone 影响机体反应，但在适当场景下使用"
          ],
          "indication_plausibility": [
            "显示出禁忌存在的原因，但其效益需进一步验证"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.65,
          "safety_risk": 0.1,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.55,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Mycophenolate mofetil 需谨慎考虑其免疫抑制风险"
          ],
          "indication_plausibility": [
            "存在禁忌，但对于个别患者可能具有不同的结果"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.62,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.45,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.6,
          "safety_risk": 0.1,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.15
        },
        "graph_signals": {
          "support_weight": 0.5,
          "contradiction_weight": 0,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Etanercept 的使用需考虑潜在风险与个体化"
          ],
          "indication_plausibility": [
            "禁忌存在，可能影响不同患者的反应"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.58,
        "components": {
          "mechanism_fit": 0.45,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.45,
          "indication_plausibility": 0.55,
          "safety_risk": 0.1,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 0.45,
          "contradiction_weight": 0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Infliximab 的使用需谨慎，特别是在 JDM 患者中"
          ],
          "indication_plausibility": [
            "应根据病史进行评估，但存有潜在风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.55,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.45,
          "indication_plausibility": 0.5,
          "safety_risk": 0.2,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 0.4,
          "contradiction_weight": 0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Rituximab 对特定患者可能存在禁忌"
          ],
          "indication_plausibility": [
            "应考虑具体的疗效与安全风险"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.52,
        "components": {
          "mechanism_fit": 0.4,
          "class_prior": 0.45,
          "pk_pd_feasibility": 0.45,
          "indication_plausibility": 0.5,
          "safety_risk": 0.25,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.2
        },
        "graph_signals": {
          "support_weight": 0.35,
          "contradiction_weight": 0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Interferon-alpha 在某些患者中需谨慎应用",
            "禁忌的潜在风险需要识别"
          ],
          "indication_plausibility": [
            "针对 JDM 患者的实施需权衡"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.48,
        "components": {
          "mechanism_fit": 0.35,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.4,
          "indication_plausibility": 0.4,
          "safety_risk": 0.3,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.25
        },
        "graph_signals": {
          "support_weight": 0.3,
          "contradiction_weight": 0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Nivolumab 可能加重 JDM 症状"
          ],
          "indication_plausibility": [
            "禁忌的强度需要进一步评估"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H6",
      "H7",
      "H8",
      "H9",
      "H10",
      "H11",
      "H12"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_mtx",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_aza",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclo",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_chloroquine",
          "type": "Drug",
          "label": "Chloroquine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dp",
          "type": "Drug",
          "label": "D-penicillamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pred",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_mmf",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_interferon_alpha",
          "type": "Drug",
          "label": "Interferon-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nivolumab",
          "type": "Drug",
          "label": "Nivolumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_jdm",
          "type": "Disease",
          "label": "Juvenile dermatomyositis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Chloroquine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_chloroquine",
          "type": "Drug",
          "label": "Chloroquine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "D-penicillamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_d_penicillamine",
          "type": "Drug",
          "label": "D-penicillamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Prednisone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Etanercept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Infliximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Interferon-alpha",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_interferon_alpha",
          "type": "Drug",
          "label": "Interferon-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Nivolumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_nivolumab",
          "type": "Drug",
          "label": "Nivolumab",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_mtx",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Methotrexate常用于自身免疫病但有潜在禁忌"
        },
        {
          "source": "n_aza",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Azathioprine对免疫抑制有禁忌"
        },
        {
          "source": "n_cyclo",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Cyclophosphamide可能加重病症"
        },
        {
          "source": "n_chloroquine",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Chloroquine用法须谨慎，存在禁忌"
        },
        {
          "source": "n_dp",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "D-penicillamine可能影响病情"
        },
        {
          "source": "n_pred",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Prednisone影响机体反应"
        },
        {
          "source": "n_mmf",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Mycophenolate mofetil需留意免疫抑制"
        },
        {
          "source": "n_etanercept",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Etanercept存在潜在风险"
        },
        {
          "source": "n_infliximab",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Infliximab应注意病史"
        },
        {
          "source": "n_rituximab",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Rituximab对某些患者禁忌"
        },
        {
          "source": "n_interferon_alpha",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Interferon-alpha需谨慎使用"
        },
        {
          "source": "n_nivolumab",
          "target": "n_jdm",
          "relation": "contraindication",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Nivolumab可能加重症状"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "score": 0.85,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Methotrexate 为免疫抑制类药物，理论上适合 JDM，但识别潜在禁忌更为重要"
        ],
        "caveats": [
          "使用 Methotrexate 可能引发严重副作用，需谨慎评估"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "score": 0.82,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Azathioprine 的免疫抑制作用与 JDM 的病理相关"
        ],
        "caveats": [
          "潜在风险依然存在，需个体化评估"
        ],
        "confidence": "high"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "score": 0.79,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Cyclophosphamide 在特定情况下可能加重 JDM"
        ],
        "caveats": [
          "安全性和疗效需进一步评估"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Juvenile dermatomyositis",
          "reason": "针对 JDM 禁忌药物的关系已经明确并有强的证据支撑"
        }
      ],
      "remaining_gaps": [
        "缺乏对部分药物潜在益处与禁忌的深入分析"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": [
        "针对每种药物的潜在危害与疗效评估需均衡考虑",
        "进一步探讨药物的个体响应和病程多样性"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "继续关注个体化治疗的重要性，尤其是在免疫抑制的风险与疗效考量间保持平衡。"
      },
      {
        "role": "Skeptic",
        "patch": "进行具体的病例分析，以验证不同药物的适应性和潜在禁忌。"
      }
    ],
    "heuristics": [
      {
        "when": "使用免疫抑制药物",
        "then": "建议监测患者的反应和症状，及时调整用药方案。"
      }
    ]
  }
}